Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Zander

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
Surgical Oncology|January 5, 2025
Impact of structured surveillance of patients with esophageal cancer following surgical resection with curative intentFriederike Baehr, Johanna Teloh-Benger, Alexander Damanakis, et al.
Journal of Neurochemistry|June 18, 2002
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgammaThomas Zander, Jürgen A Kraus, Christian Grommes, et al.
Oncotarget|February 1, 2018
High protein and mRNA expression levels of TUBB3 (class III ß-tubulin) are associated with aggressive tumor features in esophageal adenocarcinomasHeike Loeser, Simon Schallenberg, Moritz von Winterfeld, et al.
Scientific Reports|June 12, 2024
Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alterationMax Kraemer, Thomas Zander, Hakan Alakus, et al.
Cancer Research|January 21, 2006
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphomaJens M Chemnitz, Julia Driesen, Sabine Classen, et al.
Oncology Letters|May 19, 2023
Morphological, clinical and molecular characteristics in ARID1a‑deficient microsatellite‑stable oesophageal adenocarcinomaJan Rehkaemper, Florian Gebauer, Bastian Ulmer, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2023
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive diseaseAlyne Condurú Dos Santos Cunha, Adrian Georg Simon, Thomas Zander, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 29, 2020
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic dataDaniel A Hescheler, Patrick S Plum, Thomas Zander, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2015
PD-L1 expression in small cell neuroendocrine carcinomasAnne M Schultheis, Andreas H Scheel, Luka Ozretić, et al.
Soft Matter|October 29, 2015
Structure of DPPC-hyaluronan interfacial layers - effects of molecular weight and ion compositionD C Florian Wieland, Patrick Degen, Thomas Zander, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
Surgical Oncology|January 5, 2025
Impact of structured surveillance of patients with esophageal cancer following surgical resection with curative intentFriederike Baehr, Johanna Teloh-Benger, Alexander Damanakis, et al.
Journal of Neurochemistry|June 18, 2002
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgammaThomas Zander, Jürgen A Kraus, Christian Grommes, et al.
Oncotarget|February 1, 2018
High protein and mRNA expression levels of TUBB3 (class III ß-tubulin) are associated with aggressive tumor features in esophageal adenocarcinomasHeike Loeser, Simon Schallenberg, Moritz von Winterfeld, et al.
Scientific Reports|June 12, 2024
Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alterationMax Kraemer, Thomas Zander, Hakan Alakus, et al.
Cancer Research|January 21, 2006
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphomaJens M Chemnitz, Julia Driesen, Sabine Classen, et al.
Oncology Letters|May 19, 2023
Morphological, clinical and molecular characteristics in ARID1a‑deficient microsatellite‑stable oesophageal adenocarcinomaJan Rehkaemper, Florian Gebauer, Bastian Ulmer, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2023
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive diseaseAlyne Condurú Dos Santos Cunha, Adrian Georg Simon, Thomas Zander, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 29, 2020
Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic dataDaniel A Hescheler, Patrick S Plum, Thomas Zander, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2015
PD-L1 expression in small cell neuroendocrine carcinomasAnne M Schultheis, Andreas H Scheel, Luka Ozretić, et al.
Soft Matter|October 29, 2015
Structure of DPPC-hyaluronan interfacial layers - effects of molecular weight and ion compositionD C Florian Wieland, Patrick Degen, Thomas Zander, et al.
Pageof 21